You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Novo Nordisk
since
auto-detected in 161 stories
27 hours ago
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
3 days ago
AstraZeneca advances weight-loss pill to take aim at obesity leaders ○
found
a story from Financial Times ✅ › Financial Times
Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly
8 days ago
Revolutionary Wegovy Pill weight-loss drug set to be approved for use in Britain 'within days' - and it will be cheaper than injections ⊕
found
a story from The Daily Mail 💩 › The Daily Mail
The daily tablet, called the Wegovy Pill, is expected to get the greenlight from health officials, according to sources close to the drug's developer, the Danish firm Novo Nordisk.
31 days ago
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance ⊖
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
36 days ago
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk ⊕
found
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
Amazon to carry Ozempic pill at U.S. kiosks, offer same-day delivery ⊕
Amazon said on Thursday its pharmacy will stock Novo Nordisk's Ozempic pill to treat type 2 diabetes at its kiosks and offer same-day delivery of the drug.
37 days ago
Novo Nordisk CEO: Aim is to expand weight-loss market in U.S. ⊕
found
a story from CNBC ⚠️ › World News
Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales.
Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance ⊕
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
39 days ago
Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly's GLP-1 dominance ⊕
Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.
43 days ago
More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says ○
found
Eli Lilly's weight loss pill launch has been closely watched after the successful start of Novo Nordisk's Wegovy pill.